Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik C Hansen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Discovery Today. Technologies|December 14, 2017
Novel approaches to targeting BRD4Olesya A Kharenko, Henrik C Hansen
Bioorganic & Medicinal Chemistry Letters|June 19, 2021
Synthesis of NVS-BPTF-1 and evaluation of its biological activityLéa Mélin, Cyrus Calosing, Olesya A Kharenko, et al.
The Journal of Organic Chemistry|October 25, 2003
Identification of novel macrocyclic peptidase substrates via on-bead enzymatic cyclizationKristina K Hansen, Henrik C Hansen, Ryan C Clark, et al.
The Biochemical Journal|August 15, 2002
Interaction of the verotoxin 1B subunit with soluble aminodeoxy analogues of globotriaosyl ceramidesMurugesapillai Mylvaganam, Henrik C Hansen, Beth Binnington, et al.
Molecular Cancer Therapeutics|March 5, 2009
The phytochemical piceatannol induces the loss of CBL and CBL-associated proteinsAlexander C Klimowicz, Sabine A Bisson, Karm Hans, et al.
ACS Omega|September 2, 2021
Design and Synthesis of LM146, a Potent Inhibitor of PB1 with an Improved Selectivity Profile over SMARCA2Léa Mélin, Emily Gesner, Sarah Attwell, et al.
European Journal of Medicinal Chemistry|January 29, 2010
Stilbene analogs as inducers of apolipoprotein-I transcriptionHenrik C Hansen, Fabrizio S Chiacchia, Reena Patel, et al.
European Journal of Medicinal Chemistry|May 7, 2013
In vitro biosynthesis, isolation, and identification of predominant metabolites of 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one (RVX-208)Yuri L Khmelnitsky, Vadim V Mozhaev, Ian C Cotterill, et al.
Biochemical and Biophysical Research Communications|June 11, 2016
RVX-297- a novel BD2 selective inhibitor of BET bromodomainsOlesya A Kharenko, Emily M Gesner, Reena G Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2014
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphomaJoydeep Bhadury, Lisa M Nilsson, Somsundar Veppil Muralidharan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Discovery Today. Technologies|December 14, 2017
Novel approaches to targeting BRD4Olesya A Kharenko, Henrik C Hansen
Bioorganic & Medicinal Chemistry Letters|June 19, 2021
Synthesis of NVS-BPTF-1 and evaluation of its biological activityLéa Mélin, Cyrus Calosing, Olesya A Kharenko, et al.
The Journal of Organic Chemistry|October 25, 2003
Identification of novel macrocyclic peptidase substrates via on-bead enzymatic cyclizationKristina K Hansen, Henrik C Hansen, Ryan C Clark, et al.
The Biochemical Journal|August 15, 2002
Interaction of the verotoxin 1B subunit with soluble aminodeoxy analogues of globotriaosyl ceramidesMurugesapillai Mylvaganam, Henrik C Hansen, Beth Binnington, et al.
Molecular Cancer Therapeutics|March 5, 2009
The phytochemical piceatannol induces the loss of CBL and CBL-associated proteinsAlexander C Klimowicz, Sabine A Bisson, Karm Hans, et al.
ACS Omega|September 2, 2021
Design and Synthesis of LM146, a Potent Inhibitor of PB1 with an Improved Selectivity Profile over SMARCA2Léa Mélin, Emily Gesner, Sarah Attwell, et al.
European Journal of Medicinal Chemistry|January 29, 2010
Stilbene analogs as inducers of apolipoprotein-I transcriptionHenrik C Hansen, Fabrizio S Chiacchia, Reena Patel, et al.
European Journal of Medicinal Chemistry|May 7, 2013
In vitro biosynthesis, isolation, and identification of predominant metabolites of 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one (RVX-208)Yuri L Khmelnitsky, Vadim V Mozhaev, Ian C Cotterill, et al.
Biochemical and Biophysical Research Communications|June 11, 2016
RVX-297- a novel BD2 selective inhibitor of BET bromodomainsOlesya A Kharenko, Emily M Gesner, Reena G Patel, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2014
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphomaJoydeep Bhadury, Lisa M Nilsson, Somsundar Veppil Muralidharan, et al.
Pageof 2